The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

PROLONGED RETENTION OF URINE DUE TO AN ANTIDEPRESSANT DRUG

Published Online:https://doi.org/10.1176/ajp.119.5.476

A case is described of urinary retention lasting 27 days after 15 days' treatment with amitriptyline hydrochloride (Tryptizol). The interesting features are 1) the long duration of the condition after the drug was stopped and 2) the failure of a cholinergic drug (carbachol) to counteract the anti-cholinergic activity of Tryptizol.

The case demonstrates the necessity for daily examination for urinary retention of patients receiving amitriptyline HCL, particularly of cases who cannot be expected to make spontaneous complaint of urinary symptoms, due to dementia, depression or apathy.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.